BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 18177830)

  • 41. [The attitude of pregnant women to the possibilities for the prenatal screening and diagnosis of Down's syndrome in the 2nd trimester].
    Dimitrova V; Chernev T; Savova S; Stoianova M
    Akush Ginekol (Sofiia); 2000; 39(1):3-9. PubMed ID: 10826326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid prenatal diagnostic testing for Down syndrome only or longer wait for full karyotype: the views of pregnant women.
    Ryan M; Diack J; Watson V; Smith N
    Prenat Diagn; 2005 Dec; 25(13):1206-11. PubMed ID: 16353286
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of graphical and numerical presentation of hypothetical prenatal diagnosis results on risk perception.
    Siegrist M; Orlow P; Keller C
    Med Decis Making; 2008; 28(4):567-74. PubMed ID: 18566487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Normal obstetric ultrasound reduces the risk of Down syndrome in fetuses of older mothers.
    Anderson NG; Luehr B; Ng R
    Australas Radiol; 2006 Oct; 50(5):429-34. PubMed ID: 16981938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Uptake of invasive prenatal diagnostic tests in women after detection of soft markers for chromosomal abnormality on ultrasonographic evaluation.
    Sharda S; Phadke SR
    J Perinatol; 2007 Sep; 27(9):550-5. PubMed ID: 17611609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acceptance of screening and abortion for Down syndrome among Finnish midwives and public health nurses.
    Jallinoja P; Santalahti P; Toiviainen H; Hemminki E
    Prenat Diagn; 1999 Nov; 19(11):1015-22. PubMed ID: 10589051
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Abortion attitudes of pregnant women in prenatal care.
    Learman LA; Drey EA; Gates EA; Kang MS; Washington AE; Kuppermann M
    Am J Obstet Gynecol; 2005 Jun; 192(6):1939-45; discussion 1945-7. PubMed ID: 15970856
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome.
    Jaques AM; Sheffield LJ; Halliday JL
    Prenat Diagn; 2005 Aug; 25(8):656-64. PubMed ID: 16049990
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Factors affecting mothers' knowledge of genetic screening.
    Suriadi C; Jovanovska M; Quinlivan JA
    Aust N Z J Obstet Gynaecol; 2004 Feb; 44(1):30-4. PubMed ID: 15089865
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Miscarriage risk from amniocentesis performed for abnormal maternal serum screening.
    Towner D; Currier RJ; Lorey FW; Cunningham GC; Greve LC
    Am J Obstet Gynecol; 2007 Jun; 196(6):608.e1-5; discussion 608.e5. PubMed ID: 17547917
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pregnancy outcomes and intimate partner violence in New Zealand.
    Fanslow J; Silva M; Whitehead A; Robinson E
    Aust N Z J Obstet Gynaecol; 2008 Aug; 48(4):391-7. PubMed ID: 18837845
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Maternal age-specific fetal loss rates in Down syndrome pregnancies.
    Savva GM; Morris JK; Mutton DE; Alberman E
    Prenat Diagn; 2006 Jun; 26(6):499-504. PubMed ID: 16634111
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Does maternal serum screening for Down syndrome induce anxiety in younger mothers?
    Lai FM; Ng CC; Yeo GS
    Singapore Med J; 2004 Aug; 45(8):375-8. PubMed ID: 15284931
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Abnormal folate metabolism as a risk factor for first-trimester spontaneous abortion.
    Hoffman ML; Scoccia B; Kurczynski TW; Shulman LP; Gao W
    J Reprod Med; 2008 Mar; 53(3):207-12. PubMed ID: 18441727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A meta-synthesis of pregnant women's decision-making processes with regard to antenatal screening for Down syndrome.
    Reid B; Sinclair M; Barr O; Dobbs F; Crealey G
    Soc Sci Med; 2009 Dec; 69(11):1561-73. PubMed ID: 19783085
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The estimated risk of miscarriage should be corrected for induced abortion rates.
    Eskild A; Vatten LJ; Nesheim BI; Vangen S
    Acta Obstet Gynecol Scand; 2009; 88(5):569-74. PubMed ID: 19253060
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Experiences of women who decided to continue the pregnancy after diagnosis of Down's syndrome].
    Tijmstra TJ; Bosboom GJ; Bouman K
    Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2104-7. PubMed ID: 11103672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maternal education modifies the age-related increase in the birth prevalence of Down syndrome.
    Khoshnood B; Wall S; Pryde P; Lee KS
    Prenat Diagn; 2004 Feb; 24(2):79-82. PubMed ID: 14974110
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Decisions about prenatal testing for chromosomal disorders: perceptions of a diverse group of pregnant women.
    Moyer A; Brown B; Gates E; Daniels M; Brown HD; Kuppermann M
    J Womens Health Gend Based Med; 1999 May; 8(4):521-31. PubMed ID: 10839707
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preferences of women facing a prenatal diagnostic choice: long-term outcomes matter most.
    Kuppermann M; Feeny D; Gates E; Posner SF; Blumberg B; Washington AE
    Prenat Diagn; 1999 Aug; 19(8):711-6. PubMed ID: 10451513
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.